Hanspeter Honegger
Overview
Explore the profile of Hanspeter Honegger including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
238
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Mengiardi B, Honegger H, Hodler J, Exner U, Csherhati M, Bruhlmann W
AJR Am J Roentgenol
. 2004 Dec;
184(1):185-92.
PMID: 15615972
Objective: Our aim was to describe MRI and CT characteristics of primary lymphoma of bone during and after successful treatment. Conclusion: MRI showed a rapid decrease of tumor volume with...
12.
Lukaschek J, Nufer M, Maurer D, Asanger M, Honegger H, Widmer L, et al.
J Clin Oncol
. 2004 Dec;
22(24):5022-5.
PMID: 15611524
No abstract available.
13.
Risch L, Monn A, Luthy R, Honegger H, Huber A
Clin Chim Acta
. 2004 Jun;
345(1-2):79-87.
PMID: 15193980
Background: Despite the widespread use of quantitative methods to measure D-dimer, clinical decisions commonly are based only on binary test information (positive/negative). This study aimed to determine the significance of...
14.
Dubs A, Jacky E, Stahel R, Taverna C, Honegger H
J Clin Oncol
. 2004 Mar;
22(6):1158.
PMID: 15020620
No abstract available.
15.
Betticher D, Hsu Schmitz S, Totsch M, Hansen E, Joss C, von Briel C, et al.
J Clin Oncol
. 2003 May;
21(9):1752-9.
PMID: 12721251
Purpose: A multicenter, phase II trial investigated the efficacy and toxicity of neoadjuvant docetaxel-cisplatin in locally advanced non-small-cell lung cancer (NSCLC) and examined prognostic factors for patients not benefiting from...
16.
Borner M, Dietrich D, Stupp R, Morant R, Honegger H, Wernli M, et al.
J Clin Oncol
. 2002 Mar;
20(7):1759-66.
PMID: 11919232
Purpose: To determine the efficacy and tolerability of combining oxaliplatin with capecitabine in the treatment of advanced nonpretreated and pretreated colorectal cancer. Patients And Methods: Forty-three nonpretreated patients and 26...